Early changes in estimated glomerular filtration rate post‐initiation of empagliflozin in <scp>EMPEROR‐Reduced</scp>

Abstract

A mild eGFR decrease may be expected after the initiation of empagliflozin, and it is not associated with untoward heart failure, mortality, or kidney safety events. Clinicians should not be concerned with early eGFR changes post-initiation of empagliflozin.